Pfizer Inc.

NYSE:PFE   3:59:59 PM EDT
39.58
+0.38 (+0.98%)
4:03:58 PM EDT: $39.50 -0.08 (-0.19%)
Products, Strategic Combinations, Regulatory

IDEAYA And Pfizer Expand Clinical Trial Collaboration

Published: 09/24/2020 10:09 GMT
Pfizer Inc. (PFE) - Ideaya and Pfizer Expand Clinical Trial Collaboration and Supply Agreement to Evaluate Clinical Combination of Ide196 and Crizotinib in Solid Tumors Harboring Gnaq Or Gna11 Mutations.
Ideaya Biosciences Inc - Study Will Evaluate Ide196 and Crizotinib Combination Therapy in Patients With Solid Tumors Having Gnaq Or Gna11 Mutations.
Ideaya Biosciences Inc - Targeting Fpi for Crizotinib Clinical Trial Combination in Late 2020 to Early 2021.
Ideaya Biosciences Inc - Evaluating Ide196 As Monotherapy in an Ongoing Gnaq/11 Non-mum Basket Trial in Additional Solid Tumor Types.
Ideaya Biosciences Inc - Ideaya and Pfizer Have Established a Joint Development Committee.